AZD1222

Browse the articles related to this topic below.

Join our community on Guilded.

Categories
Publications

SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents – JAMA

The risk of myocarditis in this large cohort study was highest in young males after the second SARS-CoV-2 vaccine dose, and this risk should be balanced against the benefits of protecting against severe COVID-19 disease.

https://jamanetwork.com/journals/jamacardiology/fullarticle/2791253

Archive link: https://web.archive.org/web/20230000000000*/https://jamanetwork.com/journals/jamacardiology/fullarticle/2791253

Categories
Publications

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults – ClinicalTrials.gov

Brief Summary:The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

Actual Study Start Date  :August 28, 2020
Actual Primary Completion Date  :March 5, 2021
Estimated Study Completion Date  :February 14, 2023

https://clinicaltrials.gov/ct2/show/NCT04516746